Joanna L. Parish

1.6k total citations
41 papers, 1.2k citations indexed

About

Joanna L. Parish is a scholar working on Epidemiology, Molecular Biology and Oncology. According to data from OpenAlex, Joanna L. Parish has authored 41 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Epidemiology, 17 papers in Molecular Biology and 12 papers in Oncology. Recurrent topics in Joanna L. Parish's work include Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (7 papers) and Genomics and Chromatin Dynamics (7 papers). Joanna L. Parish is often cited by papers focused on Cervical Cancer and HPV Research (17 papers), Hepatitis B Virus Studies (7 papers) and Genomics and Chromatin Dynamics (7 papers). Joanna L. Parish collaborates with scholars based in United Kingdom, United States and Germany. Joanna L. Parish's co-authors include Sally Roberts, Kevin Gaston, Elliot J. Androphy, Peter L. Stern, Anthony R. Clarke, Nicholas Coleman, Christopher W. Wasson, Stephen Doxsey, Jill M. Lahti and Xiaoyu Wang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Molecular Cell.

In The Last Decade

Joanna L. Parish

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joanna L. Parish United Kingdom 21 590 561 310 220 178 41 1.2k
Jason M. Bodily United States 18 737 1.2× 474 0.8× 364 1.2× 189 0.9× 264 1.5× 35 1.2k
Seiichiro Mori Japan 17 444 0.8× 402 0.7× 208 0.7× 278 1.3× 143 0.8× 39 902
Ian J. Groves United Kingdom 18 715 1.2× 395 0.7× 252 0.8× 78 0.4× 248 1.4× 34 1.1k
Kirsten M. Edwards Australia 8 567 1.0× 444 0.8× 275 0.9× 131 0.6× 320 1.8× 12 1.1k
Nicholas A. Wallace United States 14 423 0.7× 450 0.8× 266 0.9× 100 0.5× 100 0.6× 46 841
S A Southern United Kingdom 17 663 1.1× 309 0.6× 310 1.0× 123 0.6× 155 0.9× 26 937
Cyril M. Sanders United Kingdom 18 355 0.6× 497 0.9× 176 0.6× 205 0.9× 83 0.5× 30 867
Michael C. Owens United States 6 497 0.8× 450 0.8× 211 0.7× 127 0.6× 147 0.8× 12 959
Valentina Dell’Oste Italy 22 690 1.2× 402 0.7× 196 0.6× 84 0.4× 633 3.6× 49 1.3k
Harald zur Hausen Germany 5 750 1.3× 333 0.6× 267 0.9× 172 0.8× 206 1.2× 5 1.0k

Countries citing papers authored by Joanna L. Parish

Since Specialization
Citations

This map shows the geographic impact of Joanna L. Parish's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joanna L. Parish with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joanna L. Parish more than expected).

Fields of papers citing papers by Joanna L. Parish

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joanna L. Parish. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joanna L. Parish. The network helps show where Joanna L. Parish may publish in the future.

Co-authorship network of co-authors of Joanna L. Parish

This figure shows the co-authorship network connecting the top 25 collaborators of Joanna L. Parish. A scholar is included among the top collaborators of Joanna L. Parish based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joanna L. Parish. Joanna L. Parish is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parish, Joanna L., et al.. (2025). De-regulation of aurora kinases by oncogenic HPV; implications in cancer development and treatment. PubMed. 19. 200314–200314. 3 indexed citations
2.
Harris, James Michael, Andrea Magrì, Roland Arnold, et al.. (2024). CTCF regulates hepatitis B virus cccDNA chromatin topology. Journal of General Virology. 105(1). 5 indexed citations
3.
Parish, Joanna L., et al.. (2022). Lying low-chromatin insulation in persistent DNA virus infection. Current Opinion in Virology. 55. 101257–101257. 5 indexed citations
4.
Stockton, Joanne, Thomas Günther, Andrew D. Beggs, et al.. (2021). The chromatin insulator CTCF regulates HPV18 transcript splicing and differentiation-dependent late gene expression. PLoS Pathogens. 17(11). e1010032–e1010032. 16 indexed citations
5.
Batis, Nikolaos, Jennifer Bryant, Yao Jiang, et al.. (2021). The anti-tumour activity of DNA methylation inhibitor 5-aza-2′-deoxycytidine is enhanced by the common analgesic paracetamol through induction of oxidative stress. Cancer Letters. 501. 172–186. 16 indexed citations
6.
7.
D’Arienzo, Valentina, Guillaume Giraud, James Michael Harris, et al.. (2020). The CCCTC ‐binding factor CTCF represses hepatitis B virus enhancer I and regulates viral transcription. Cellular Microbiology. 23(2). e13274–e13274. 14 indexed citations
8.
Wing, Peter A. C., Tamara Davenne, Jochen M. Wettengel, et al.. (2019). A dual role for SAMHD1 in regulating HBV cccDNA and RT-dependent particle genesis. Life Science Alliance. 2(2). e201900355–e201900355. 17 indexed citations
9.
Bryant, Jennifer, Nikolaos Batis, M. Gill Hartley, et al.. (2019). Repurposed quinacrine synergizes with cisplatin, reducing the effective dose required for treatment of head and neck squamous cell carcinoma. Oncotarget. 10(50). 5229–5244. 12 indexed citations
10.
Schlecht, Nicolas F., Richard V. Smith, Thomas J. Belbin, et al.. (2018). Association of an intact E2 gene with higher HPV viral load, higher viral oncogene expression, and improved clinical outcome in HPV16 positive head and neck squamous cell carcinoma. PLoS ONE. 13(2). e0191581–e0191581. 29 indexed citations
11.
Morgan, Ethan L., Christopher W. Wasson, Victoria A. McGuire, et al.. (2018). STAT3 activation by E6 is essential for the differentiation-dependent HPV18 life cycle. PLoS Pathogens. 14(4). e1006975–e1006975. 76 indexed citations
12.
13.
Weaver, Margaret L., Joanna L. Parish, Ingrid Brück Bøgh, et al.. (2015). Vehicle Systems and Excipients Used in Minipig Drug Development Studies. Toxicologic Pathology. 44(3). 367–372. 9 indexed citations
14.
Prystowsky, Michael B., Nicole Kawachi, Cristina Montagna, et al.. (2013). Inhibition of Plk1 and Cyclin B1 Expression Results in Panobinostat-Induced G2 Delay and Mitotic Defects. Scientific Reports. 3(1). 2640–2640. 12 indexed citations
15.
Prystowsky, Michael B., Richard V. Smith, Nicole Kawachi, et al.. (2009). The histone deacetylase inhibitor LBH589 inhibits expression of mitotic genes causing G2/M arrest and cell death in head and neck squamous cell carcinoma cell lines. The Journal of Pathology. 218(4). 467–477. 44 indexed citations
16.
Parish, Joanna L., Jack Rosa, Xiaoyu Wang, et al.. (2006). The DNA helicase ChlR1 is required for sister chromatid cohesion in mammalian cells. Journal of Cell Science. 119(23). 4857–4865. 89 indexed citations
17.
Parish, Joanna L., et al.. (2004). Herpes simplex virus VP22–human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death. Biotechnology and Applied Biochemistry. 40(2). 157–165. 22 indexed citations
18.
Dell, Ghislaine, et al.. (2003). Comparison of the Structure and DNA-binding Properties of the E2 Proteins from an Oncogenic and a Non-oncogenic Human Papillomavirus. Journal of Molecular Biology. 334(5). 979–991. 33 indexed citations
19.
Davidson, Emma J., Michael D. Brown, Deborah J. Burt, et al.. (2001). Human T cell responses to HPV 16 E2 generated with monocyte-derived dendritic cells. International Journal of Cancer. 94(6). 807–812. 13 indexed citations
20.
Parish, Joanna L., et al.. (2000). The Human Papillomavirus (HPV) 16 E2 Protein Induces Apoptosis in the Absence of Other HPV Proteins and via a p53-dependent Pathway. Journal of Biological Chemistry. 275(1). 87–94. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason M. Bodily Breakdown of academic impact, for papers by Seiichiro Mori Breakdown of academic impact, for papers by Ian J. Groves Breakdown of academic impact, for papers by Kirsten M. Edwards Breakdown of academic impact, for papers by Nicholas A. Wallace Breakdown of academic impact, for papers by S A Southern Breakdown of academic impact, for papers by Cyril M. Sanders Breakdown of academic impact, for papers by Michael C. Owens Breakdown of academic impact, for papers by Valentina Dell’Oste Breakdown of academic impact, for papers by Harald zur Hausen
Rankless by CCL
2026